1. Home
  2. XNET vs ORGO Comparison

XNET vs ORGO Comparison

Compare XNET & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xunlei Limited

XNET

Xunlei Limited

HOLD

Current Price

$4.83

Market Cap

358.4M

Sector

Technology

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.45

Market Cap

299.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XNET
ORGO
Founded
2003
1985
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
358.4M
299.8M
IPO Year
2011
2016

Fundamental Metrics

Financial Performance
Metric
XNET
ORGO
Price
$4.83
$2.45
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
562.7K
728.1K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1600.00
EPS
N/A
N/A
Revenue
N/A
$564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$26.27
P/E Ratio
$0.29
N/A
Revenue Growth
N/A
17.04
52 Week Low
$4.02
$2.04
52 Week High
$11.03
$7.08

Technical Indicators

Market Signals
Indicator
XNET
ORGO
Relative Strength Index (RSI) 39.02 49.72
Support Level $4.52 $2.26
Resistance Level $6.11 $2.59
Average True Range (ATR) 0.32 0.12
MACD 0.00 0.00
Stochastic Oscillator 30.69 49.06

Price Performance

Historical Comparison
XNET
ORGO

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: